Maxim Research - New York, page-6

Very prescient post.

Company executives spend a great deal of their time and energy thinking about the finances of the businesses they are managing, irrespective of the scale of those businesses or where they are in their corporate evolution.

Sourcing of capital to fund operating expenses, asset maintenance, development, growth, and to service capital providers appropriately is what managers spend a large part of their careers thinking about.

The manner in which it is financed, is a very big deal for every business.

So, it never ceases to amaze me how so many followers of MSB actively ignore the financials of the company. "She'll be apples", appears to be the prevailing attitude, as if capital is free and capital markets represent the magic pudding of money-on-tap, to be accessed wherever and whenever the fancy takes MSB directors.

People who simply say, "All that matters is the science; they money will take care of itself" fail to understand to concept of the cost of capital and how, for MSB, instead of going down as the company progresses towards commercialisation - which is what would normally happen - MSB's cost of capital has gone up significantly over time.

To say its all about the trials, and little else, is to bury your head in the sand.

Because, it's really all about the money.
All things flow from the money.

Because without money, there is nothing.
No trials, no research, no development.
Nada. Zip. Zilch.